(Q43246029)

17 November 2017

0 references

Prostate-specific antigen: a misused and maligned prostate cancer biomarker (English)

1 reference

17 November 2017

0 references

Alan R Kristal

3

0 references

Catherine M Tangen

series ordinal

2

object named as

Catherine M Tangen

1 reference

17 November 2017

Ian M Thompson

1

1 reference

PMC publication ID

2579315

17 November 2017

language of work or name

English

0 references

publication date

28 October 2008

1 reference

Journal of the National Cancer Institute

17 November 2017

1 reference

17 November 2017

100

1 reference

17 November 2017

21

1 reference

17 November 2017

1487-1488

1 reference

Obesity and prostate cancer mortality

17 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579315

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579315

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579315

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579315

Surrogate end points in clinical trials: are we being misled?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579315

Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579315

Surrogate end points and FDA approval: a tale of 2 lipid-altering drugs

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579315

Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18957671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJN368

1 reference

17 November 2017

1 reference

PMC publication ID

2579315

17 November 2017

PubMed publication ID

18957671

1 reference

PMC publication ID

2579315